SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Jan-24 6:54 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Jan-24 | Exercise (in-the money or at-the-money) | 1,234,640 | $12.74 | $15,729,300.00 | 23% 5.35M to 6.58M | |
27-Sep-22 4:46 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Sep-22 | Grant | 639,456 | $7.35 | $4,700,000.00 | 14% 4.71M to 5.35M | |
27-Sep-22 4:46 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Sep-22 | Grant | 1,360,540 | $7.35 | $10,000,000.00 | 25% 5.35M to 6.71M | |
30-Sep-21 5:48 PM View: | Cue Health Inc. (HLTH) | 28-Sep-21 | Conversion | 8,192,470 | -- | -- | 100% 0 to 8.19M | |
21-Sep-21 10:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 17-Sep-21 | Market Purchase | 1,542,550 | $9.40 | $14,500,000.00 | 49% 3.17M to 4.71M | 10% |